Fund size | GBP 608 m |
Total expense ratio | 0.20% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 9.04% |
Inception/ Listing Date | 13 May 2013 |
Distribution policy | Distributing |
Distribution frequency | Quarterly |
Fund domicile | Netherlands |
Fund Provider | VanEck |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Bank International GmbH, Amsterdam branch |
Investment Advisor | Van Eck Associates Corporation |
Custodian Bank | State Street Bank International GmbH, Amsterdam branch |
Revision Company | KPMG Accountants N.V. |
Fiscal Year End | 31 December |
Swiss representative | FIRST INDEPENDENT FUND SERVICES AG |
Swiss paying agent | Helvetische Bank AG |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Daiichi Sankyo Co., Ltd. | 0.68% |
Prosus NV | 0.66% |
Gilead Sciences, Inc. | 0.63% |
Wuxi Biologics Cayman | 0.63% |
The Cigna Group | 0.61% |
Merck & Co., Inc. | 0.61% |
Eli Lilly & Co. | 0.58% |
NOVO NORDISK A/S -B | 0.57% |
The TJX Cos | 0.56% |
Genmab A/S | 0.56% |
YTD | +6.69% |
1 month | +2.77% |
3 months | +7.32% |
6 months | +14.91% |
1 year | +19.81% |
3 years | +29.46% |
5 years | +72.17% |
Since inception (MAX) | +199.21% |
2023 | +13.87% |
2022 | -7.48% |
2021 | +19.43% |
2020 | +11.94% |
Current dividend yield | 1.83% |
Dividends (last 12 months) | GBP 0.50 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.50 | 2.15% |
2023 | GBP 0.56 | 2.45% |
2022 | GBP 0.52 | 2.06% |
2021 | GBP 0.42 | 1.97% |
2020 | GBP 0.41 | 2.06% |
Volatility 1 year | 9.04% |
Volatility 3 years | 11.65% |
Volatility 5 years | 14.73% |
Return per risk 1 year | 2.19 |
Return per risk 3 years | 0.77 |
Return per risk 5 years | 0.78 |
Maximum drawdown 1 year | -6.30% |
Maximum drawdown 3 years | -15.35% |
Maximum drawdown 5 years | -26.64% |
Maximum drawdown since inception | -26.64% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | TSWE | - - | - - | - |
Borsa Italiana | EUR | TSWE | ITSWE | .ITSWE | Société Générale |
Borsa Italiana | EUR | - | TSWE IM ITSWE | TSWE.MI TSWEINAV=IHSM | |
Euronext Amsterdam | EUR | TSWE | TSWE NA ITSWE | TSWE.AS TSWEINAV=IHSM | Flow Traders Jane Street Société Générale Susquehanna |
Euronext Brussels | EUR | TSWE | TSWE BB ITSWE | TSWE.BR TSWEINAV=IHSM | |
London Stock Exchange | USD | TSWE | TSWE LN ITSWE | TSWE.L ITSWEINAV.PA | Société Générale |
London Stock Exchange | GBP | TSGB | TSGB LN ITSWE | TSGB.L ITSWEINAV.PA | Société Générale |
SIX Swiss Exchange | CHF | TSWE | TSWE SE ITSWE | TSWE.S ITSWEINAV.PA | Société Générale |
XETRA | EUR | TSWE | TSWE GY ITSWE | TSWE.DE TSWEINAV=IHSM | Société Générale |
Fund name | Fund Size in m € (AuM) | TER in % p.a. | Distribution policy | Replication method |
---|---|---|---|---|
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 16 | 0.59% p.a. | Accumulating | Full replication |
HANetf HAN-GINS Cloud Technology Equal Weight UCITS ETF | 14 | 0.59% p.a. | Accumulating | Full replication |